Zydus Lifesciencesnbsp;has received final approval from the United States Food and Drug Administration USFDA to market Topiramate Extended-Release Capsules 25 mg 50 mg 100 mg 150 mg and 200 mg USRLD Qudexy XR Extended-Release capsules
Topiramate Extended-Release capsule is indicated to prevent and control seizures in people with epilepsy It may also be used to prevent migraine headaches
The drug will be manufactured at the groups formulation manufacturing facility at Ahmedabad SEZ India
Topiramate Extended-Release capsule had annual sales of USD 688 mn in the United States according to IQVIA data IQVIA MAT Sep 2022
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
